Basal ganglia pathways

The basal ganglia are a group of deep brain nuclei — including the striatum (caudate and putamen), globus pallidus, subthalamic nucleus, and substantia nigra — that fine-tune motor activity. They do not command muscles directly; instead, they modulate the thalamus, which in turn excites the motor cortex. Signals flow through two parallel circuits: the direct and indirect pathways.

The direct pathway promotes movement. Cortical input excites the striatum, which inhibits the globus pallidus internus; because the pallidus normally inhibits the thalamus, this "inhibition of an inhibitor" releases the thalamus to drive the motor cortex. The indirect pathway does the opposite: striatal signals route through the globus pallidus externus and subthalamic nucleus, ultimately increasing pallidal inhibition of the thalamus and suppressing movement. Healthy motor control is the balance between the two — a go signal and a brake.

Dopamine from the substantia nigra pars compacta tips this balance toward movement: it stimulates the direct pathway through D1 receptors and inhibits the indirect pathway through D2 receptors. That dual action explains the classic movement disorders. In Parkinson's disease, loss of nigral dopaminergic neurons lets the indirect pathway dominate, producing bradykinesia and rigidity. In Huntington's disease, degeneration of indirect-pathway striatal neurons releases the brake, producing chorea.

The USMLE Step 1 tests the wiring of both pathways, the D1/D2 receptor logic, and the pathway-level explanation of Parkinson's, Huntington's, and hemiballismus (subthalamic nucleus damage), while the MCAT covers the basal ganglia's role in movement regulation within its behavioral neuroscience content.